PharmaEngine gains on MM-398 data

PharmaEngine Inc. (GreTai:4162) gained NT$17.50 to NT$270 on Friday after partner Merrimack Pharmaceuticals Inc. (NASDAQ:MACK) reported on Thursday that MM-398 plus chemotherapy as second-line treatme...